MAY 1ST OF GREENS
engages in the development of transformative medicines based on messenger ribonucleic acid. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. GOOD OF START of the company of may from the breakdown. from $46.8 up tp 49.6. GOOD BULLISH!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.